This company seems to have been delisted
Reason: Rebranded as Artivion (AORT)
Source: https://www.prnewswire.com/news-releases/cryolife-announces-corporate-rebranding-and-changes-name-to-artivion-301462581.html
Reason: Rebranded as Artivion (AORT)
Source: https://www.prnewswire.com/news-releases/cryolife-announces-corporate-rebranding-and-changes-name-to-artivion-301462581.html
CryoLife
CRY
$17.88
Share price
1.42%
Change (1 day)
-21.51%
Change (1 year)
Categories
Market capitalization of CryoLife (CRY)
Last known market cap: $0.70 Billion USD
As of July 2025 CryoLife has a market cap of $0.70 Billion USD. This makes CryoLife the world's 6500th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of CryoLife from 2001 to 2022
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2022 | $0.70 B | -12.14% |
| 2021 | $0.80 B | -12.76% |
| 2020 | $0.91 B | -9.77% |
| 2019 | $1.01 B | -3.11% |
| 2018 | $1.04 B | 51.64% |
| 2017 | $0.69 B | 10.02% |
| 2016 | $0.62 B | 104.74% |
| 2015 | $0.30 B | -3.59% |
| 2014 | $0.31 B | 3.25% |
| 2013 | $0.30 B | 80.34% |
| 2012 | $0.17 B | 26.72% |
| 2011 | $0.13 B | -10.68% |
| 2010 | $0.15 B | -17.28% |
| 2009 | $0.18 B | -33.08% |
| 2008 | $0.27 B | 24.39% |
| 2007 | $0.21 B | 15.26% |
| 2006 | $0.19 B | 131.05% |
| 2005 | $82.46 M | -50.19% |
| 2004 | $0.16 B | 44.95% |
| 2003 | $0.11 B | -14.57% |
| 2002 | $0.13 B | -76.4% |
| 2001 | $0.56 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Baxter BAX | $14.72 B | 1,994.40% | 🇺🇸 USA |
 Edwards Lifesciences EW | $45.78 B | 6,410.70% | 🇺🇸 USA |
 Medtronic MDT | $115.21 B | 16,283.50% | 🇮🇪 Ireland |
 Stryker Corporation SYK | $148.83 B | 21,065.41% | 🇺🇸 USA |
 Integra LifeSciences IART | $0.97 B | 39.13% | 🇺🇸 USA |
 Boston Scientific BSX | $152.67 B | 21,611.66% | 🇺🇸 USA |
 Teleflex TFX | $5.14 B | 631.44% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $377.51 B | 53,583.91% | 🇺🇸 USA |